Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Limited contamination in the Dutch–Belgian randomized lung cancer screening trial (NELSON)
Lung Cancer, 10/12/09
Baecke E et al. – The rate of contamination among male subjects of the control arm of the NELSON trial is low and is not likely to jeopardize the power of the trial.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Image-Guided Radiofrequency Ablation of Lung Neoplasm in 100 Consecutive Patients by a Thoracic Surgical Service
Annals of Thoracic Surgery, 10/23/09
Relevance Score: 67%
The Association between Polymorphisms of XPD and Susceptibility of Lung Cancer: A meta Analysis
Chinese Journal of Lung Cancer, 10/21/09
Relevance Score: 67%
hsa-miR-125a-5p Enhances Invasion in Non-small Cell Lung Carcinoma Cell Lines by Upregulating Rock-1
Chinese Journal of Lung Cancer, 10/20/09
Relevance Score: 67%
CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians
Lung Cancer, 10/06/09
Relevance Score: 67%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/04/09
Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904
Journal of Clinical Oncology, 12/04/09
Nutrition Aspects of Lung Cancer
Nutrition in Clinical Practice, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


